Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells

Oncology Research

Volumn 10, Issue 6, 1998, Pages 287-293

  Sakukawa, Rieko ^a   Murakami, Koji ^a,b   Ikeda, Takashi ^a,b   Yamada, Yuji ^a,b   Saiki, Ikuo ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Apoptosis; Liver metastasis; Matrix metalloproteinase; TAC 101; Tumor invasion; U PA

Indexed keywords

ANTINEOPLASTIC AGENT; BENZOIC ACID DERIVATIVE; COLLAGENASE; GELATINASE; GELATINASE A; GELATINASE B; METALLOPROTEINASE; RETINOIC ACID; TAC 101; TRIMETHYLSILYL DERIVATIVE; UROKINASE;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER INVASION; CANCER TRANSPLANTATION; CELL CULTURE; COLON TUMOR; DRUG EFFECT; ENZYMOLOGY; FEMALE; LIVER TUMOR; METASTASIS; MOUSE; PATHOLOGY;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOATES; COLLAGENASES; COLONIC NEOPLASMS; FEMALE; GELATINASES; LIVER NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; TRETINOIN; TRIMETHYLSILYL COMPOUNDS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032239783     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Daly, L. M.; Kemeny, N. E. Metastatic cancer to the liver. In: DeVita, V. T.; Hellman, S.; Rosenberg, S. A., eds. Cancer: Principles and practice of oncology, 5th ed. Philadelphia: Lippincott; 1997:2551-2570.
2. Doci, R.; Gennari, L.; Bignami, P.; Mpntalto, F.; Morabito, A.; Bozzetti, F. One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br. J. Surg. 78:797-801; 1991.
3. Okuyama, K.; Isono, K.; Juang, I. K.; Onoda, S.; Ochiai, T.; Yamamoto. Y.; Koide, Y.; Satoh, H. Evolution of treatment for gastric cancer with liver metastasis. Cancer 55:2498-2505; 1985.
4. Fidler, I. J. Selection of successive tumor lines for metastasis. Nature 242:148; 1973.
5. Ohnishi, Y.; Sakamoto, T.; Fujii, H.; Kimura, F.; Murata, J.; Tazawa, K.; Fujimaki, M.; Sato, Y.; Kondo, M.; Une, Y.; Uchino, J.; Saiki, I. Characterization of a liver metastatic variant of murine colon 26 carcinoma cells. Tumor Biol. 18:113-122; 1996.
6. Murakami, K.; Wierzba, K.; Sano, M.; Shibata, J.; Yonekura, K.; Hashimoto, A.; Sato, K.; Yamada, Y. TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolonas the life-span. Clin. Exp. Metastasis 16:323-331; 1998.
7. Hashimoto, Y.; Kagetika, H.; Kawachi, E.; Fukasawa, H.; Saito, G.; Shudo, K. Evaluation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. Biol. Pharm. Bull. 19:1322-1328; 1996.
8. Hendrix, M. J. C.; Wood, W. R.; Seftor, E. A.; Lotan, D.; Nakajima, M.; Misiorowski, R. L.; Seftor, R. E. B.; Stetler-Stevenson, W. G.; Bevacqua, S. J.; Liotta, L. A.; Sobel, M. E.; Raz, A.; Lotan, R. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res. 50:4121-4130; 1990.
9. Oikawa, T.; Okayasu, I.; Ashino, H.; Morita, I.; Murota, S.; Shudo, K. Three novel synthetic retinoids, Re 80, Am580, and Am80, all exhibit anti-angiogenic activity in vivo. Eur. J. Pharmacol. 249:113-116; 1993.
10. Pollard, M.; Luckert, P. H. The inhibitory effect of 4-hydroxyphe
11. nyl retinamidc (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund-Wistar rats. Cancer Lett. 59:159-163; 1991.
12. Huang, M.; Ye, Y.; Chen, S.; Chai, J.; Lu, J.L.; Zhoa, L.; Gu, L.; Wang, Z. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567-572; 1988.
13. Warrell, R. P., Jr.; Frankel, S. R.; Miller, W. H., Jr.; Schienberg, D. A.; Itri, L. M.; Hittelman, W. N.; Vyas, R.; Andreeff, M.; Tafuri, A.; Jakubowski, A.; Gabrilove, J.; Gordon, M. S.; Domitrovsky, E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med. 324:1385-1393; 1991.
14. Hong, W. K.; Lippman, S. M.; Itri, L. M.; Karp, D. D.; Lee, J. S.; Byers, R. M.; Schantz, S. P.; Kramer, A. M.; Lotan, R.; Peters, L. J.; Dimery, I. W.; Brown, B. W.; Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323:795-801; 1990.
15. Lippman, S. M.; Shin, D. M.; Lee, J.; Batsakis, J. G.; Lotan, R.; Tainsky, M. A.; Hittelman, W. N.; Hong, W. K. p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res. 55:16-19; 1995.
16. Mackay, A. R.; Ballin, M.; Pelina, M. D.; Farina, A. R.; Nason, A. M.; Hartzler, J. L.; Thorgeirsson, U. P. Effect of phorbol ester and cytokines on matrix metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12:168-184; 1992.
17. Nørth, P.; Nerlov, C.; Blasi, F.; Johnsen, M. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acids Res. 18:5009-5017; 1990.
18. Bernhardt, G.; Reile, H., Birnbock, H.; Spruss, T.; Schonenberger, H. Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J. Cancer Res. Clin. Oncol. 118:36-43; 1992.
19. Sellins, K. S.; Cohen, J. J. Gene induction by γ-irradiation leads to DNA fraamentation in lymphocytes. J. Immunol. 139:3199-3206; 1987.
20. Ala, N.; Oku, T.; Hattori, M.; Fujii, H.; Nakajima, M.; Saiki, I. Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells. Oncol. Res. 12:503-511; 1996.
21. Matsuo, O.; Sakai, T.; Bando, H.; Okada, K.; Nakajima, S.; Takagi, O.; Izaki, S. Plasminogen activator in bronchoalveolar fluid. Haemostasis 16:43-50; 1986.
22. Saito, K.; Oku, T.; Ata, N.; Miyashiro, H.; Hattori, M.; Saiki, I. A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitor. Biol. Pharm. Bull. 20:345-348; 1997.
23. McArdle, B. H. The significance of differences between means. A simulation study. Comp. Biochem. Physiol. A 87:979-982; 1987.
24. Hochberg, Y.; Tamhane, A. C. 1.2 Multivariate t-distribution. In: Multiple comparison procedures. New York: John Wiley & Sons; 1987:374-375.
25. Takeuchi, T.; Niina, K.; Kubonishi, I.; Miyoshi, I. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain a of plasminogen activators. Thromb. Haemost. 63:259-264; 1990.
26. Marutsuka, K.; Suzumiya, J.; Kataoka, H.; Komada, N.; Koono, M.; Sumiyoshi, A. Correlation between urokinase-typc plasminogen activator production and the matastatic ability of human rectal cancer cells. Invasion Metastasis 11:181-191; 1991.
27. Reich, R.; Thompson, E. W.; Iwamoto, Y.; Martin, G. R.; Deason, J. R.; Fuller, G. C.; Miskin, R. Effect of inhibitors of plasminogen activator, serine proteases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res. 48:3307-3312; 1988.
28. Turpeenniemi-Hujanen, T.; Thorgeirsson, U. P.; Hart, I. R.; Grant, S. S.; Liotta, L. A. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potental. J. Natl. Cancer Inst. 75:99-103; 1985.
29. Ura, H.; Bonfil, R. D.; Reich, R.; Reddel, R.; Pfeifer, A.; Harris, C. C.; Klein-Szanto, A. J. P. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res. 49:4615-4621; 1989.
30. Zhang, L. X.; Mills, K. J.; Dawson, M. I.; Collins, S. J.; Jetten, A.
31. M. Evidence for the involvement of retinoic acid receptor RARα-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem. 270:6022-6029; 1995.
32. Mangelsdorf, D. J.; Umesono, K.; Evans, R. M. The retinoid receptors. In: Sporn, M. B.; Roberts, A. B.; Goodman, D. S., eds. The retinoids: Biology, chemistry, and medicine, 2nd ed. New York: Raven Press; 1994:319-349.
33. Shüle, R.; Rangarajan, P.; Yang, N.; Kliewer, S.; Ransone, L.; Bolado, J.; Verma, I. M.; Evans, R. M. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. USA 88:6092-6096; 1991.
34. Angel, P.; Karin, M. The role of Jun, Fos and AP-1 complex in cell-proliferation and transformation. Biochem. Biophys. Acta 1072:129-157; 1991.
35. Finkenzeller, G.; Technau, A.; Marme, D. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem. Biophys. Res. Commun. 208:432-439: 1995.
36. 1, is mediated by the AP-1 complex. Mol. Cell. Biol. 10:1492-1497; 1990.
37. Sato, H.; Seiki, M. Reglatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395-105: 1993.
38. Nerlov, C; Rørth, P.; Blasi. F.: Johnsen, M. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1592; 1997.
39. Huhtala, P.; Tuuttila, A.; Chow, L. T.; Lohi, J.; Keski-Oja, J.; Tryggvason, K. Complete structure of the human gene for 92-kDa type IV collagenase. J. Biol. Chem. 266:16485-16490; 1991.
40. Huhtala, P.; Chow, L. T.; Tryggvason, K. Structure of the human type IV collagenase. J. Biol. Chem. 265:11077-11082; 1990.
41. Hollas, W.; Blasi, F.; Boyd, D. Role of the urokinase receptor in
42. facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res. 51:3690-3695; 1991.
43. Kobayashi, H.; Ohi, H.; Sugimura, M.; Shinohara, H.; Fujii, T.; Terao, T. Inhibition in vitro ovarian cancer cell invasion by modulation of urokinase type plasminogen activator and cathepsin B. Cancer Res. 52:3610-3614; 1992.
44. Liotta, L. A.; Stetler-Stevenson, W. G. Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res. Suppl. 51:5054-5059; 1991.
45. Sullivan, L. M.; Quigley, J. P. An anticatalytic monoclonal antibody to avian plasminogen activator: Its effect on behavior of RSV-transformed chick fibroblast. Cell 45:905-915; 1986.
46. Baramova, E. N.; Bajou, K.; Remade, A.; L'Hoir, C.; Krell, H. W.; Weidle, U. H.; Noel, A.; Foidart, J. M. Involvement of PA/plasmin system in the processing of pro-MMP and in the second step of pro-MMP-2 activation. FEBS J. 405:157-162; 1997.
47. Goldberg, G. I.; Strongin, A.; Vollier, I. E.; Genrich, T.; Marmer, B. L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267:4583-4591; 1992.
48. Mars, W. M.; Liu, M. L.; Kitson, R. P.; Gordfarb, R. H.; Gabauer, M. K.; Michalopoulos, G. K. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology 21:1695-1701; 1995.
49. Naka, D.; Ishii, T.; Yoshiyama, Y.; Miyazawa, K.; Hara, H.; Hishida, T.; Kitamura, N. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J. Biol. Chem. 267:20114-20119; 1992.
50. O'Connell, J. P.; Willenbrock, F.; Docherty, A. J. P.; Eaton, D.; Murphy, G. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J. Biol. Chem. 269:14967-14973; 1994.